Anemia is Associated with an Adverse Outcome in Patients with Atrial Fibrillation: Insights Form the Re-ly Trial

被引：0
|
作者：
Westenbrink, B. Daan [1 ]
Alings, Marco [2 ]
Connolly, Stuart [3 ,4 ]
Eikelboom, Iohn [5 ]
Ezekowitz, Michael D. [6 ]
Oldgren, Jonas [5 ]
Yang, Sean [3 ,4 ]
Pogue, Janice [3 ,4 ]
Yusuf, Salim [3 ,4 ]
Wallentin, Lars [7 ]
van Gilst, Wiek H. [1 ]
机构：
[1] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
[2] Amphia Hosp, Breda, Netherlands
[3] Populat Hlth Rsch Inst, Hamilton, ON, Canada
[4] McMaster Univ, Hamilton, ON, Canada
[5] Uppsala Univ, Uppsala Clin Rsch Cntr, Uppsala, Sweden
[6] Lankenau Inst Med Res & Heart Cntr, Wynnewood, PA USA
[7] Uppsala Univ, Uppsala, Sweden
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Anticoagulants; Hemoglobin; Myocardial Infraction; Outcomes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18466
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Dabigatran Versus Warfarin in Patients with Atrial Fibrillation: Analysis in Asian Population in RE-LY Trial
    Hori, M.
    Connolly, S. J.
    Zhu, J.
    Liu, L. S.
    Lau, C-P
    Pais, P.
    Xavier, D.
    Kim, S. S.
    Omar, R.
    Dans, A. L.
    Tan, R. S.
    Chen, J-H
    Tanomsup, S.
    Watanabe, M.
    Koyanagi, M.
    Ezekowitz, M. D.
    Reilly, P. A.
    Wallentin, L.
    Yusuf, S.
    CEREBROVASCULAR DISEASES, 2012, 34 : 9 - 9
  • [22] Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)
    Nagarakanti, Rangadham
    Wallentin, Lars
    Noack, Herbert
    Brueckmann, Martina
    Reilly, Paul
    Clemens, Andreas
    Connolly, Stuart J.
    Yusuf, Salim
    Ezekowitz, Michael D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (08): : 1204 - 1209
  • [23] Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial
    Ferreira, Jorge
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    Brueckmann, Martina
    Fraessdorf, Mandy
    Reilly, Paul A.
    Yusuf, Salim
    Wallentin, Lars
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (09) : 1053 - 1061
  • [24] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. Results of the RE-LY study
    不详
    KARDIOLOGIYA, 2009, 49 (10) : 75 - 76
  • [25] Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis
    Pablo A. Mendoza
    William F. McIntyre
    Emilie P. Belley-Côté
    Jia Wang
    Ratika Parkash
    Clare L. Atzema
    Alexander P. Benz
    Jonas Oldgren
    Richard P. Whitlock
    Jeff S. Healey
    Journal of Thrombosis and Thrombolysis, 2022, 53 : 74 - 82
  • [26] Growth differentiation factor 15 is an independent marker of risk of major bleeding in atrial fibrillation: insights from the RE-LY trial
    Hijazi, Z.
    Oldgren, J.
    Andersson, U.
    Connolly, S. J.
    Eikelboom, J. W.
    Ezekowitz, M. D.
    Reilly, P. A.
    Siegbahn, A.
    Yusuf, S.
    Wallentin, L.
    EUROPEAN HEART JOURNAL, 2016, 37 : 429 - 429
  • [27] Clinical Experience with Dabigatran in Patients with Atrial Fibrillation: What Should the Hematologist Re-Ly on?
    Chapin, John
    Basciano, Paul
    DeSancho, Maria
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S181 - S181
  • [28] Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis
    Mendoza, Pablo A.
    McIntyre, William F.
    Belley-Cote, Emilie P.
    Wang, Jia
    Parkash, Ratika
    Atzema, Clare L.
    Benz, Alexander P.
    Oldgren, Jonas
    Whitlock, Richard P.
    Healey, Jeff S.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (01) : 74 - 82
  • [29] Efficacy and Safety of Dabigatran Compared With Warfarin in Patients With Atrial Fibrillation and Normal Renal Function Over Time: Insights From the RE-LY Trial
    Hijazi, Ziad
    Hohnloser, Stefan H.
    Oldgren, Jonas
    Andersson, Ulrika
    Connolly, Stuart J.
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Reilly, Paul A.
    Yusuf, Salim
    Wallentin, Lars
    CIRCULATION, 2015, 132
  • [30] Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE-LY Trial
    Hijazi, Ziad
    Verdecchia, Paolo
    Oldgren, Jonas
    Andersson, Ulrika
    Reboldi, Gianpaolo
    Di Pasquale, Giuseppe
    Mazzotta, Giovanni
    Angeli, Fabio
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    Yusuf, Salim
    Wallentin, Lars
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (02):
12345